Italia markets closed
FTSE MIB
33.629,21 -107,19 (-0,32%) Dow Jones
38.667,89 +442,23 (+1,16%) Nasdaq
16.151,97 +311,01 (+1,96%) Nikkei 225
38.236,07 -37,98 (-0,10%) Petrolio
78,41 -0,54 (-0,68%) Bitcoin EUR
57.420,14 +2.585,30 (+4,71%)
DVA Jan 2025 47.500 put
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 10:31AM EDT. Mercato aperto.
| Chiusura precedente | 0,3500 |
| Aperto | 0,3500 |
| Denaro | 0,0000 |
| Lettera | 1,9500 |
| Prezzo d'esercizio | 47,50 |
| Scadenza | 2025-01-17 |
| Min-Max giorno | 0,3500 - 0,3500 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 15 |
GlobeNewswireNuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
© 2024 Yahoo. Tutti i diritti riservati.